4.7 Article

Commissioning and clinical implementation of an Autoencoder based Classification-Regression model for VMAT patient-specific QA in a multi-institution scenario

期刊

RADIOTHERAPY AND ONCOLOGY
卷 161, 期 -, 页码 230-240

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2021.06.024

关键词

Machine learning; VMAT patient-specific QA; Multi-institution validation; Commissioning; Clinical implementation

资金

  1. National Key Research and Development Program [2020YFE020088]
  2. National Natural Science Foundation of China [11735003, 11975041, 11961141004, 61773380, 82022035, 81071237]
  3. Beijing Municipal Commission of Science and Technology Collabo-rative Innovation Project [Z201100005620012, Z181100001518005]
  4. Beijing Natural Science Foundation [7202223]
  5. Capital's Funds for Health Improvement and Research [20202Z40919]
  6. fundamental Research Funds for the Central Universities
  7. Key project of Henan Provincial Department of Education [20B320035]
  8. NIH/NCI P30 Cancer Center Support Grant [CA008748]
  9. China International Medical Foundation [HDRS2020030206]

向作者/读者索取更多资源

The study aimed to commission and implement an ACLR model for VMAT patient-specific quality assurance in a multi-institution scenario. Through multi-institutional validation, the model's prediction and classification accuracy were confirmed under different equipment and systems, with established routine QA for clinical use.
Background and purpose: To commission and implement an Autoencoder based Classification-Regression (ACLR) model for VMAT patient-specific quality assurance (PSQA) in a multi-institution scenario. Materials and methods: 1835 VMAT plans from seven institutions were collected for the ACLR model com-missioning and multi-institutional validation. We established three scenarios to validate the gamma passing rates (GPRs) prediction and classification accuracy with the ACLR model for different delivery equipment, QA devices, and treatment planning systems (TPS). The prediction performance of the ACLR model was evaluated using mean absolute error (MAE) and root mean square error (RMSE). The classification performance was evaluated using sensitivity and specificity. An independent end-to-end test (E2E) and routine QA of the ACLR model were performed to validate the clinical use of the model. Results: For multi-institution validations, the MAEs were 1.30-2.80% and 2.42-4.60% at 3%/3 mm and 3%/2 mm, respectively, and RMSEs were 1.55-2.98% and 2.83-4.95% at 3%/3 mm and 3%/2 mm, respec-tively, with different delivery equipment, QA devices, and TPS, while the sensitivity was 90% and speci-ficity was 70.1% at 3%/2 mm. For the E2E, the deviations between the predicted and measured results were within 3%, and the model passed the consistency check for clinical implementation. The predicted results of the model were the same in daily QA, while the deviations between the repeated monthly mea-sured GPRs were all within 2%. Conclusions: The performance of the ACLR model in multi-institution scenarios was validated on a large scale. Routine QA of the ACLR model was established and the model could be used for VMAT PSQA clinically. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 161 (2021) 230-240

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据